country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-187908

Copy Link Print Information

Trabzanoflast

Trabzanoflast (Compound C3) is an orally active NLRP3 inflammasome inhibitor. Trabzanoflast can be used in studies related to diet-induced obesity.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 2953675-40-4
Formel: C₁₆H₁₅N₅O₃
Molecular Weight:325.32

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

Trabzanoflast Chemical Structure

CAS. Nr.: 2953675-40-4

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- In Vitro
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

Trabzanoflast (Compound C3) is an orally active NLRP3 inflammasome inhibitor. Trabzanoflast can be used in studies related to diet-induced obesity^[1]^[2].

IC₅₀ & Target^[2]

NLRP3

In Vitro

The NLRP3 inflammasome is an intracellular multiprotein complex. Upon sensing various danger signals, it assembles and activates, mediating the maturation and release of IL‑1β/IL‑18 as well as pyroptosis, and driving innate immune inflammatory responses.

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Chemical Information

CAS. Nr. 2953675-40-4
Molecular Weight 325.32
Formel C₁₆H₁₅N₅O₃
SMILES

O=C1C2=C(C(C)=NN1CC(NC3=NC=CC=N3)=O)OC(C4CC4)=C2
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Handling Instructions (2659 KB)

Verweise

[1]. WHO Drug Information, Vol. 40, No. 2, 2026

[2]. Alan Paul Watt, et al. Nlrp3 inhibitors and glp-1 agonists combination therapies. WO2025153532A1. 2026-07-16.

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen